%20(2).webp)
%20(1)%20(1).webp)
El probiótico #1 del mundo para prevenir y tratar trastornos intestinales.*²
%20(8).svg)
%20(4).svg)
%20(6).svg)
.webp)
.svg)
Cuenta con Enterogermina durante:
.webp)
%20(1)%20(1)%20(1).webp)
.webp)
.webp)
Referencias
Nicholas Hall, 2024
- Ghelardi et al (2015). Survival and persistence of Bacillus clausii in the human gastrointestinal tract following oral administration as spore-based probiotic formulation. Journal of Applied Microbiology 119, 552-559.
- Vecchione A et al (2018). Compositional Quality and Potential Gastrointestinal Behavior of Probiotic Products Commercialized in Italy. Front Med (Lausanne) 5:59.
- Giua et al (2024). A Prospective Real‑World Study of Bacillus clausii Evaluating Use, Treatment Habits and Patient Satisfaction in Italian Community Pharmacies: The PEGASO Study. Drugs - Real World Outcomes (2024) 11:137–147.
- Acosta et al (2022). Bacillus clausii for Gastrointestinal Disorders: A Narrative Literature Review. Adv Ther (2022) 39:4854–4874.
- Paparo L et al. Protective action of Bacillus clausii probiotic strains in an in vitro model of Rotavirus infection. Sci Rep. 2020;10:12636.
- Lahiri K et al. Bacillus clausii As An Adjuvant Therapy In Acute Childhood Diarrhoea. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) 2015;14:74-76
- 1 Weiss GA & Hennet T. Cell Mol Life Sci. 2017;74:2959-2977
- Tarasiuk A & Fichna J. J Expert Rev Clin Pharmacol. 2019;12:921-30
- Amabebe E, et al. Br J Nutr. 2020;123:1127-1137.
- Gulas E, et al. Psychiatr Pol. 2018;52:1023-1039.
- Leeming ER, et al. Nutrients. 2019;11(12):2862.
- Danis R & Wawruch M. Cent Eur J Public Health. 2022;30:20–25
Referencias para el reto de 7 días (A-D)
A- Lahiri K et al. Bacillus clausii As An Adjuvant Therapy In Acute Childhood Diarrhoea. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) 2015;14:74-76.
B- Giua et al (2024). A Prospective Real‑World Study of Bacillus clausii Evaluating Use, Treatment Habits and Patient Satisfaction in Italian Community Pharmacies: The PEGASO Study. Drugs - Real World Outcomes (2024) 11:137–147.
C- Ghelardi et al (2015). Survival and persistence of Bacillus clausii in the human gastrointestinal tract following oral administration as spore-based probiotic formulation. Journal of Applied Microbiology 119, 552-559.
D- Castro et al (2019). Bacillus clausii as adjunctive treatment for acute community-acquired diarrhea among Filipino children: a large-scale, multicenter, open-label study (CODDLE). Tropical Diseases, Travel Medicine and Vaccines 5:14.
.webp)
.webp)
.webp)
.webp)
